Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 12
- +1 vs. Q2 2024
- Portfolio value
- $906.8M
- +$110.9M (+13.9%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | 1,202,804 | $690.1M | 76.1% | +55,825+4.9% | Added | History |
| iShares MSCI India ETF46429B598 | ETF | 2,425,144 | $141.9M | 15.7% | 00.0% | Unchanged | – |
| Vanguard Ftse All-World Ex-US Index Fund922042775 | ETF | 507,600 | $32.0M | 3.5% | +507,600 | New | – |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $14.7M | 1.6% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 989,410 | $10.1M | 1.1% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 1,307,858 | $6.09M | 0.7% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,627,643 | $3.92M | 0.4% | 00.0% | Unchanged | History |
| MEHCQChrome Holding Co. | CLASS A COM | 10,243,122 | $3.59M | 0.4% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,015,705 | $1.96M | 0.2% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 657,899 | $1.32M | 0.1% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 87,696 | $1.05M | 0.1% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 170,833 | $1.76K | <0.1% | 00.0% | Unchanged | – |